STAT3-coordinated migration facilitates the dissemination of diffuse large B-cell lymphomas

Yi Ru Pan, Chih Cheng Chen, Yu Tien Chan, Hsiao Jung Wang, Fan Tso Chien, Yeng Long Chen, Jing Lan Liu, Muh Hwa Yang*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

38 Scopus citations


The motile characteristics and mechanisms that drive the dissemination of diffuse large B-cell lymphoma (DLBCL) are elusive. Here, we show that DLBCL initiates dissemination through activating STAT3-mediated amoeboid migration. Mechanistically, STAT3 activates RHOH transcription, which competes with the RhoGDP dissociation inhibitor RhoGDIγ to activate RhoA. In addition, activated STAT3 regulates microtubule dynamics and releases ARHGEF2 to activate RhoA. Both the JAK inhibitor ruxolitinib and the microtubule stabilizer Taxol suppress DLBCL cell dissemination in vivo. A clinical DLBCL sample analysis shows that STAT3-driven amoeboid movement is particularly important for the transition from stage I to stage II. This study elucidates the mechanism of DLBCL dissemination and progression and highlights the potential of combating advanced DLBCL with a JAK/STAT inhibitor or microtubule stabilizer to reduce DLBCL motility; these findings may have a great impact on the development of patient-tailored treatments for DLBCL.

Original languageEnglish
Article number3696
JournalNature Communications
Issue number1
StatePublished - 1 Dec 2018


Dive into the research topics of 'STAT3-coordinated migration facilitates the dissemination of diffuse large B-cell lymphomas'. Together they form a unique fingerprint.

Cite this